Related by context. All words. (Click for frequent words.) 74 Overactive Bladder 74 Bosutinib 74 metastatic malignant 73 Fondaparinux 73 Adjunctive 73 NAVISTAR R 73 Complicated Skin 73 Romiplostim 73 Improves Outcomes 73 Nebulized 73 Meets Primary Endpoint 72 Chronic Sinusitis 72 Intravitreal 72 Oral Fingolimod 72 icatibant 72 Noxafil 72 Relapsing Multiple Sclerosis 72 Long Term Efficacy 72 Adjuvant Treatment 72 myelodysplastic myeloproliferative diseases 72 Demonstrates Positive 72 Ranolazine 72 Known hypersensitivity 72 Dasatinib 72 Certolizumab pegol 72 Hydroxyurea 71 Ziprasidone 71 Hormone Refractory Prostate Cancer 71 Patients Treated With 71 Severe Sepsis 71 methylnaltrexone bromide 71 vapreotide acetate 71 guanfacine extended release 71 Chronic Heart Failure 71 Shows Efficacy 71 Natalizumab 71 Pulmonary Arterial Hypertension 71 gastrointestinal stromal tumors GIST 71 Acute Ischemic Stroke 71 See CLINICAL PHARMACOLOGY 71 PEGylated anti 71 cinacalcet 71 Idiopathic Pulmonary Fibrosis 71 SPRYCEL ® 71 Plaque Psoriasis 71 Pivotal Phase III 71 FDA APPROVES 71 Vidaza azacitidine 71 Interferon beta 1b 71 Lamotrigine 71 Teriparatide 71 Adalimumab 71 Single Dose 71 Prospective Randomized 70 Patients Receiving 70 Prolongs Survival 70 Eculizumab 70 Bronchiectasis 70 TNF Tumor Necrosis Factor 70 Peripheral Arterial 70 levocetirizine 70 ribavirin USP 70 Abrupt discontinuation 70 aripiprazole Abilify 70 Relapsing Remitting Multiple Sclerosis 70 R lenalidomide 70 Moxifloxacin 70 Atypical Hemolytic Uremic Syndrome 70 overactive bladder syndrome 70 Clinical Trial Results 70 Tyrosine Kinase Inhibitor 70 Tolvaptan 70 PEGylated Fab fragment 70 Newly Diagnosed Multiple Myeloma 70 Thromboembolic 70 Pemetrexed 70 R Saizen R 70 diabetic gastroparesis 70 Allergic Rhinitis 70 ACTEMRA TM 70 Degarelix 70 Pivotal Clinical Trial 70 ZOLINZA 70 ® lenalidomide 70 Betaferon R 70 Kamada AAT 70 Denufosol 70 Tiotropium 70 FDA Approvals 70 Investigational Treatment 70 Treated Patients 70 Metastatic Prostate Cancer 70 INVEGA ® 70 invasive candidiasis 70 Atomoxetine 70 Phase 2b Clinical Trial 69 acute bronchospasm 69 recurrent glioblastoma multiforme 69 Glatiramer Acetate 69 Granted Orphan Drug 69 Inhalation Aerosol 69 Chronic Hepatitis B 69 Lubiprostone 69 Intravenous Formulation 69 alfa 2a 69 Tocilizumab 69 Clinical Efficacy 69 hyperphenylalaninemia HPA due 69 pioglitazone hydrochloride 69 Controlled Trial 69 Nilotinib 69 Bazedoxifene 69 sitaxsentan 69 CIMZIA R 69 Treating Chronic 69 SNT-MC#/idebenone 69 Pafuramidine 69 bone marrow reticulin deposition 69 esophageal candidiasis 69 Schizophrenia Treatment 69 Bosentan 69 Renal Artery 69 pioglitazone HCl 69 Angioedema 69 Thromboembolism 69 EVIZON TM 69 fosbretabulin 69 Mycophenolate Mofetil 69 atrophic vaginitis 69 Placebo Controlled Trial 69 Study Evaluating 69 reflux disease GERD 69 Pooled Analysis 69 Aflibercept 69 Adjuvant Chemotherapy 69 FUSILEV enhances 69 imipramine Tofranil 69 Immune Mediated 69 Heart Failure Patients 69 Phase III Clinical Trial 69 acetonide FA 69 Warfarin Coumadin 69 Myelodysplastic Syndromes 69 ORENCIA ® 69 Temsirolimus 69 Mirapexin 69 Clinical Outcome 69 Inhalation Solution 69 headache abdominal pain 69 Acute Heart Failure 69 See WARNINGS 69 Benign Prostatic Hyperplasia 69 Tacrolimus 69 Ischemic 69 Advanced Melanoma 69 Heterozygous Familial Hypercholesterolemia 69 Interferon beta 1a 69 Phase 2b Trial 69 Tesamorelin 69 AA Amyloidosis 69 Danazol 69 Demonstrate Significant 69 FASLODEX 69 Previously Treated 69 Posaconazole 69 Thrombotic 68 Combination REOLYSIN R 68 Demonstrates Efficacy 68 Patients Undergoing 68 topical calcineurin inhibitors 68 STELARA TM 68 Secondary Hyperparathyroidism 68 sapropterin dihydrochloride 68 adalimumab Humira 68 Carbamazepine 68 Primary Hypercholesterolemia 68 Zorbtive TM 68 ergot derivatives 68 AVASTIN 68 Lenalidomide 68 Bivalirudin 68 abacavir Ziagen 68 Kuvan sapropterin dihydrochloride 68 Fingolimod 68 palifermin 68 Completes Patient Enrollment 68 Monotherapy 68 solifenacin succinate 68 #mg BID [001] 68 pediatric Crohn disease 68 Myelodysplastic Syndrome MDS 68 Myelofibrosis 68 relapsing multiple sclerosis 68 efalizumab 68 Vitrasert R 68 Diabetic Neuropathy 68 Platinol ® 68 induce orthostatic hypotension 68 Acute Renal Failure 68 Dupuytren Contracture 68 Cilostazol 68 Etanercept 68 Peginterferon 68 alfuzosin 68 Oral Spray 68 Suicidality 68 alpha 2a 68 Desvenlafaxine 68 sitagliptin metformin 68 Reduces Mortality 68 Dual Antiplatelet Therapy 68 CIMZIA TM certolizumab pegol 68 ARIXTRA R 68 Hematologic 68 Fluticasone 68 Sipuleucel T 68 Peginterferon alfa 2b 68 RoACTEMRA 68 thetreatment 68 malignant ascites 68 treat benign prostatic 68 Safinamide 68 Methylnaltrexone 68 Thiazolidinediones 68 Renal Cell Carcinoma 68 clevidipine 68 basiliximab 68 Antitumor Activity 68 Prophylactic Treatment 68 Nesiritide 68 Silodosin 68 Antipsychotic 68 systemic hypotension 68 lamotrigine Lamictal 68 Hepatotoxicity 68 Juvenile Idiopathic Arthritis 68 ACE Inhibitors 68 Novel Oral 68 Pediatric Patients 68 Omalizumab 68 intravascular hemolysis 68 Itraconazole 68 Invasive Fungal Infections 68 leukotriene receptor antagonist 68 Renal Impairment 68 Unstable Angina 68 AVAPRO 68 Aliskiren 68 Epratuzumab 68 Exacerbation 68 CLINICAL PHARMACOLOGY 68 Dementia Related Psychosis 68 Zarnestra 68 Sevelamer 68 Diabetic Macular Edema 68 Golimumab 68 myeloid metaplasia 68 Intracoronary 68 Melphalan 68 buccal tablets 68 Parnate 68 moderate hepatic impairment 68 Initiate Clinical Trial 68 ATACAND 68 Parathyroid Hormone 68 Phase IIb Trial 68 Chronic Bronchitis 68 cysteamine bitartrate 68 Angiotensin Converting Enzyme 68 Tracleer ® bosentan 68 IN PATIENTS WITH 68 ACTOS ® 68 5 Fluorouracil 68 benign prostatic hypertrophy BPH 68 cytomegalovirus infection 68 Node Positive 68 Pivotal Study 68 Antiplatelet 68 FDA Accepts 68 salmeterol fluticasone 68 Zoloft sertraline 68 Raptiva R 68 Meta Analysis 68 AERIUS 68 brand ciclesonide HFA 68 Alpha interferons including 68 Refractory Hodgkin Lymphoma 68 Receives Orphan Drug Designation 68 Rheumatoid 68 Prostatic 68 Expanded Indication 68 Therapy Reduces 68 ipratropium bromide 68 nimodipine 68 inhalation powder 68 Low Dose 68 lipid elevations 68 chronic thromboembolic pulmonary 68 verteporfin 68 pregabalin Lyrica 68 liposome injection 67 Chronic Renal Failure 67 psoriatic arthritis PsA 67 glucocorticoid induced osteoporosis 67 colesevelam HCl 67 XYZAL R 67 Achieves Primary Endpoint 67 Enzyme Replacement Therapy 67 ALVESCO ® 67 Zeldox 67 Bucindolol 67 Improves Survival 67 Polyneuropathy 67 Myelodysplastic Syndrome 67 catheter occlusion 67 Demonstrates Significant 67 Hospital Acquired Pneumonia 67 Ophena TM 67 Knee Osteoarthritis 67 Adjunctive Therapy 67 Daptomycin 67 Investigational Compound 67 Hypercholesterolemia 67 Tigecycline 67 Delayed Graft Function 67 Kepivance 67 Hypertensive Patients 67 Castration Resistant Prostate Cancer 67 Efficacy Trial 67 diarrhea predominant irritable 67 invasive aspergillosis 67 PEGINTRON TM 67 Sifrol ® 67 atherosclerotic renal artery stenosis 67 Squalamine 67 PEG IFN 67 mitoxantrone plus 67 denileukin diftitox 67 Interferon Alfa 67 Pharmacokinetics PK 67 Infected Patients 67 Liver Failure 67 oxypurinol 67 Pegylated Liposomal Doxorubicin 67 nicardipine 67 Recombinant Human 67 Neoadjuvant 67 Paliperidone Palmitate 67 heparin induced thrombocytopenia 67 systemic fungal infections 67 TO AVOID PREGNANCY WHILE 67 Fabry Disease 67 Cimzia TM 67 Mg Usa 67 Seasonal Allergic Rhinitis 67 Drug Candidate 67 EFFEXOR XR 67 Cardiotoxicity 67 mesilate 67 NDA Submission 67 MULTAQ 67 Diabetic Foot Ulcer 67 xanthine oxidase inhibitor 67 Lupus Nephritis 67 Femara letrozole 67 quetiapine Seroquel 67 Hsp# Inhibitor 67 epoetin alpha 67 Controlled Study 67 disease GERD 67 Beta Blocker 67 headache nasopharyngitis 67 Malignant Glioma 67 Kuvan R 67 MGd 67 Rilonacept 67 J Am Coll 67 GOUT 67 LYSTEDA 67 Decitabine 67 Postmenopausal 67 paroxetine sertraline 67 sunitinib Sutent 67 thalidomide Thalomid 67 Catena ® 67 interferon gamma 1b 67 riociguat 67 non splenectomized 67 piroxicam 67 Initiates Enrollment 67 treatmentof 67 generation purine nucleoside 67 Pivotal Trial 67 Oxybutynin 67 ALVESCO R 67 Oral Formulation 67 CYP#A# substrate 67 Neupro R 67 Anthracycline 67 Decompensated Heart Failure 67 Budesonide 67 Carvedilol 67 Renal Function 67 Shows Promise Against 67 Clinical Trial Evaluating 67 Skin Structure Infections 67 serotonin norepinephrine reuptake inhibitor 67 nucleotide analogue 67 Invasive Breast Cancer 67 Allogeneic 67 Fludara ® 67 BENICAR HCT 67 Candesartan 67 Accelerated Partial Breast Irradiation 67 Critical Limb Ischemia CLI 67 Randomized Phase 67 Abbott HUMIRA 67 Fulvestrant 67 haematologic 67 SNT MC# 67 Sanvar R 67 non metastatic osteosarcoma 67 tegaserod 67 complement inhibitor eculizumab 67 Shows Statistically Significant 67 Alteplase 67 immunomodulatory agents 67 Positive Opinion 67 alpha1 antitrypsin deficiency 67 Vildagliptin 67 overactive bladder OAB 67 Sodium oxybate 67 rheumatoid arthritis osteoarthritis ankylosing 67 corifollitropin alfa 67 voriconazole 67 Ropinirole 67 Efficacy Results 67 Begins Dosing 67 Fluconazole 67 Left Ventricular 67 Immunosuppressant 67 Toremifene 67 Non inferiority 67 Hormone Receptor Positive 67 Bifeprunox 67 Perforomist ™ Inhalation Solution 67 HER2 Positive Breast Cancer 67 Endometrial Cancer 67 INTEGRILIN R 67 Relapsed Refractory 67 Atopic Dermatitis 67 Acute Myocardial Infarction 67 hepatorenal syndrome 67 SEROQUEL R 67 adult chronic ITP 67 Treprostinil 67 Central Retinal Vein 67 treat chronic sinusitis 67 lucinactant 66 intranasal formulation 66 TMS Therapy 66 Helicobacter pylori eradication 66 paricalcitol 66 oropharyngeal candidiasis OPC 66 Gel repository corticotropin injection 66 itraconazole Sporanox 66 Irritable Bowel 66 Systemic Sclerosis 66 active ankylosing spondylitis 66 #-# Full Text 66 diabetic kidney 66 Plus Ribavirin 66 rilonacept 66 Ozurdex 66 Bepreve TM 66 perioperatively 66 Hematological 66 RAPAMUNE 66 anterior uveitis 66 DEXILANT 66 docetaxel Taxotere ® 66 Soft Tissue Sarcoma 66 NSAID induced 66 Chemotherapy induced 66 Fluvastatin 66 Occlusive Disease 66 Vandetanib 66 Naive Patients 66 briakinumab 66 IND Application 66 Chronic Hepatitis C 66 Darusentan 66 bullous 66 Mg Uk 66 Tezampanel 66 cromolyn sodium 66 Subgroup Analysis 66 IONSYS TM 66 HDL Selective Delipidation 66 Demonstrates Sustained 66 Xyzal ® 66 Patients Treated 66 Raptiva ® 66 RENAL 66 Linezolid 66 Frozen Shoulder Syndrome 66 Progressive Multifocal Leukoencephalopathy 66 Intravenous immunoglobulin 66 miconazole Lauriad ® 66 rasagiline tablets 66 interferon ribavirin 66 Initiates Clinical Trial 66 Phase IIa Clinical Trial 66 bronchial hyperresponsiveness 66 selective A2A adenosine receptor 66 Phase Ib Clinical Trial 66 NAGS deficiency 66 Tasimelteon 66 Loceryl ® 66 Tasigna nilotinib 66 etanercept Enbrel 66 selective modulator 66 R entecavir 66 Bronchodilator 66 Major Depressive Disorder MDD 66 flecainide 66 Fungal Infections 66 Randomized Double blind 66 Neovascular Age Related Macular 66 somatostatin analog 66 overactive bladder symptoms 66 relapsing remitting MS RRMS 66 ST Elevation Myocardial 66 Hepatocellular Carcinoma 66 By JENNIFER LEARN 66 mycophenolic acid 66 Hyperlipidemia 66 efaproxiral 66 Patency 66 Rheumatoid Arthritis Patients 66 antiarrhythmic drug 66 prucalopride 66 reuptake inhibitor 66 Cinacalcet 66 Treatment Resistant 66 Pegloticase 66 GW# [003] 66 Gastrointestinal GI 66 oral prodrug 66 Telithromycin 66 Arranon 66 desvenlafaxine succinate 66 pharmacokinetic PK study 66 topical gel formulation 66 Interferon Beta 66 Paraplatin ® 66 paroxetine Paxil 66 orally inhaled 66 Hypotension 66 ß blockers 66 Cypher Sirolimus 66 Microplasmin 66 lichen planus 66 MYLOTARG 66 haloperidol Haldol 66 Pirfenidone 66 RhuDex 66 acute mania 66 Microalbuminuria 66 pseudobulbar affect PBA 66 Aviptadil 66 Sprycel dasatinib 66 Is Well Tolerated 66 bisoprolol 66 Files IND 66 refractory gout 66 Irinotecan 66 Phase 2b Study 66 ribavirin Copegus ® 66 hypereosinophilic syndrome 66 Tardive dyskinesia 66 Antitumor 66 de novo kidney transplant 66 Etravirine 66 Teva Provides Update 66 POSIDUR TM 66 Diabetic Macular Edema DME 66 Female Sexual Arousal 66 CYT# potent vascular disrupting 66 Lambert Eaton Myasthenic 66 Hypoactive Sexual Desire Disorder 66 anthracyclines taxanes 66 RISPERDAL ® 66 zoledronate 66 Study Demonstrates 66 Intravesical 66 Benign Prostatic Hyperplasia BPH 66 Metastatic Colorectal Cancer 66 Pegylated 66 Transurethral 66 II Clinical Trial 66 Significantly Improved 66 Exelon rivastigmine 66 Initiate Phase 66 anticholinergic agents 66 Percutaneous Tibial Nerve Stimulation 66 Significantly Improves 66 Indomethacin 66 Non Alcoholic Steatohepatitis 66 Dose Ranging Study 66 Captopril 66 Gonal f 66 Relapsed Multiple Myeloma 66 Clolar ® 66 MDS MPD 66 Bisphosphonate 66 ribavirin RBV 66 divalproex sodium 66 Diastolic Heart Failure 66 ® pioglitazone HCl 66 Myoblast 66 TLK# 66 epoprostenol 66 Chronic Myeloid Leukemia 66 Xelox 66 Azacitidine 66 deep venous thromboses 66 BARACLUDE R 66 Symptom Relief 66 Showed Significant 66 Commonly prescribed 66 Selective serotonin reuptake inhibitors 66 BARACLUDE ® 66 sertraline Zoloft 66 Patient Outcomes 66 dasatinib Sprycel ® 66 alkylating agent 66 terlipressin 66 Mitoxantrone 66 beta 1a 66 INVEGA ™ 66 First Patient Enrolled 66 Survival Benefit 66 candesartan cilexetil 66 Disease Modifying 66 Actimmune ® 66 Novel Compound 66 R bisoprolol Euthyrox 66 leukemia AML 66 Asacol R 66 HuMax EGFr 66 gefitinib Iressa 66 Chemoradiation 66 Vicriviroc 66 Coronary Artery Bypass Graft 66 Rivastigmine 66 cytopenias 66 secondary hyperparathyroidism 66 Paxil paroxetine 66 Well Tolerated 66 chronic eosinophilic leukemia 66 pain palliation 66 AMMONUL R sodium phenylacetate 66 severe oral mucositis 66 Placebo Controlled Study 66 Peptic Ulcer 66 Inhaled Corticosteroids 66 HeFH 66 Venlafaxine 66 Corticosteroid 66 AZILECT ® 66 cardiovascular calcification 66 Combination Treatment 66 Elderly Patients 66 Electrical Stimulation 66 relapsed MM 66 sorafenib tablets 66 antiarrhythmic drugs 66 Multidrug 66 See CONTRAINDICATIONS 66 sorafenib Nexavar 66 Treatment Naive Patients 66 Drug Eluting Stent System 66 anagrelide 66 Bevacizumab 66 External Beam 66 noscapine 66 Donepezil 66 Improved Survival 66 Phase 2a Trial 66 Completes Enrollment 66 venlafaxine Effexor 66 gadobutrol 66 Ambrisentan 66 B Cell Lymphoma 66 chronic idiopathic thrombocytopenic purpura 66 Carbaglu 66 Adenomas 66 Actinic Keratosis 66 Saquinavir 66 Oral Mucositis 66 Myocardial Perfusion Imaging 66 Toxicities 66 HCl capsules 66 Combo Therapy 66 agomelatine 66 KETEK 65 TYGACIL 65 Microwave Ablation System 65 orally inhaled migraine 65 nitrofurantoin 65 Pegylated Interferon 65 Adefovir 65 oral beclomethasone dipropionate 65 Severe Asthma 65 Pemphigus 65 dopamine partial agonist 65 mild renal insufficiency 65 TREATMENT OF 65 Postherpetic Neuralgia 65 Acute Decompensated Heart Failure 65 ara C 65 Endarterectomy 65 Phase 2a Clinical Trial 65 Phase III Pivotal Trial 65 Trobalt 65 Janssen Risperdal 65 Transdermal Patch 65 VIVITROL ® 65 eosinophilic asthma 65 Intrathecal 65 Hemodialysis Patients 65 Critical Limb Ischemia 65 Diabetic Patients 65 cisplatin gemcitabine 65 DOXIL 65 reduce serum phosphate 65 humanized interleukin 6 65 Rotavirus Vaccine 65 bortezomib Velcade 65 chemoradiation therapy 65 abacavir sulfate lamivudine 65 Trabectedin 65 Bare Metal Stent 65 Liver Injury 65 Postmenopausal hormone therapy 65 Mylan Receives Approval 65 Appears Safe 65 superficial basal cell carcinoma 65 Tyrosine Kinase Inhibitors 65 Non Invasive Treatment 65 Cytotoxicity 65 oropharyngeal candidiasis 65 Double Blind Placebo 65 TMP SMX 65 Valsartan 65 kidney urologic 65 Randomized Study 65 Febuxostat 65 Antiviral Therapy 65 Severe Primary IGFD 65 arthritis PsA 65 Diabetic Nephropathy 65 venous thromboembolic disease 65 knee osteoarthritis OA 65 Cimzia ® certolizumab pegol 65 FOR FURTHER INFORMATION ABOUT 65 Presents Preclinical Data 65 PULMICORT RESPULES 65 Tanespimycin 65 atypical Hemolytic Uremic Syndrome 65 Metastatic Melanoma 65 Nonspecific 65 APTIVUS 65 Anticoagulant 65 Sodium Injection 65 Trial Evaluating 65 Xyfid TM 65 novel oral anticoagulant 65 apomorphine hydrochloride 65 monoclonal antibody conjugated 65 Lung Injury 65 Adjuvant Therapy 65 Orally administered 65 Aridol TM 65 Aztreonam Lysine 65 refractory chronic lymphocytic 65 cediranib 65 Phase III Trial 65 Gastrointestinal bleeding 65 Breast Cancer Recurrence 65 Oropharyngeal Candidiasis 65 Quetiapine 65 BENICAR 65 included exfoliative dermatitis 65 prescribed proton pump 65 Hydralazine 65 levetiracetam Keppra 65 SUPPRELIN R LA 65 ORENCIA R 65 Alequel 65 Eluting Stent 65 Bone Metastases 65 Acute Coronary Syndromes ACS 65 CINQUIL 65 Lymphoid 65 Reminyl galantamine 65 chronic immune thrombocytopenic 65 Improve Survival 65 Community Acquired Pneumonia 65 Abciximab 65 SUTENT ® 65 oxaliplatin Eloxatin 65 dexamethasone intravitreal implant 65 opioid induced 65 Aortic Stenosis 65 Embolization 65 Estrogen deficiency 65 opioid induced constipation OIC 65 Lowers Risk 65 Conjugate 65 phenyl salicylate methylene blue 65 torsade de pointes 65 mycophenolate mofetil MMF 65 Venous Thromboembolism 65 Tracleer bosentan 65 Metabolic Disorder 65 cough dyspnea 65 Granulocyte Colony Stimulating Factor 65 cetuximab Erbitux R 65 Xeloda ® 65 Luveris 65 EGFR TKI 65 Pazopanib 65 Novel Inhibitor 65 Plaquenil 65 INSPIRE Trial Phase III 65 Abatacept 65 dihydrochloride 65 Galantamine 65 ziprasidone Geodon 65 DPNP 65 Clinical Practice Guideline 65 administered concomitantly 65 Remission Maintenance 65 Amgen Neulasta R 65 Eszopiclone 65 Cancidas 65 Ranibizumab 65 renal artery stenting 65 Contrast Enhanced 65 Hedgehog Pathway Inhibitor 65 Anticoagulation 65 Risk Stratification 65 Gastroesophageal Reflux Disease 65 Double Blind Randomized 65 Elagolix 65 Initiates Phase III 65 reflux esophagitis 65 Glucocorticoid 65 Clostridium difficile Infection 65 diarrhea fatigue asthenia 65 Percutaneous vertebroplasty 65 Mimpara 65 JAK2 Inhibitor 65 Biolimus A9 65 Percutaneous Transluminal Coronary Angioplasty 65 Coadministration 65 generalized anxiety disorder GAD 65 ULORIC 65 Liprotamase 65 Gastrointestinal Stromal Tumors 65 estramustine 65 pentoxifylline 65 CTAP# 65 Coronary Arteries 65 Dacogen decitabine 65 Restless Legs Syndrome RLS 65 vecuronium 65 Pharmacodynamics 65 STRIDE PD 65 Sustained Release 65 AGILECT R 65 Pivotal Phase 65 Generalized Anxiety Disorder 65 R metformin Concor 65 refractory cutaneous T 65 Glatiramer acetate 65 TOPAMAX R 65 null responder 65 hepatic insufficiency 65 Tasigna prolongs 65 Friedreich Ataxia FRDA 65 diuretics beta blockers 65 Capecitabine 65 ACOMPLIA R 65 Hyperkalemia 65 Calcium Acetate 65 Anti VEGF 65 FOLFOX6 65 infliximab Remicade 65 conivaptan 65 ADP receptor antagonist 65 SPIRIVA ® 65 mcg BID 65 TNF Blockers 65 achieved CCyR 65 Premature Infants 65 ankylosing spondylitis AS 65 ARIXTRA 65 vidofludimus 65 MetroGel 65 Cutaneous T 65 amitriptyline Elavil 65 Chronic Insomnia 65 recurrent herpes labialis 65 FOLOTYN ® 65 QVAR ® 65 Forodesine HCl 65 Chronic Lung 65 corticosteroid dexamethasone 65 sargramostim 65 cardiotoxic 65 Desvenlafaxine Succinate 65 Ribavirin causes 65 known teratogen substance 65 receiving XGEVA 65 VAPRISOL 65 β blockers 65 Egrifta 65 lanreotide 65 Successfully Completes Phase 65 Chemotherapy Induced 65 neurogenic bladder 65 #mg Tablets [002] 65 post herpetic neuralgia PHN 65 Immunomedics Announces 65 Paliperidone ER 65 oral dual endothelin 65 Resistant Hypertension 65 Statistically Significant 65 thromboembolic complications 65 CP CPPS 65 Ovidrel 65 mcg QD 65 AVONEX ® 65 Infliximab 65 Overactive Bladder OAB 65 R pioglitazone HCl 65 platelet inhibitor 65 aldosterone antagonists 65 levodopa carbidopa 65 PROMACTA 65 rotigotine transdermal patch 65 brivaracetam 65 capsules USP 65 Catheter Ablation 65 Ischemic Stroke 65 Fracture Risk 65 stable angina pectoris 65 Receptor Antagonists 65 Muraglitazar 65 leukopenia pancytopenia thrombocytopenia 65 Submits NDA 65 Phase IIb Clinical Trial 65 Follicular Lymphoma 65 Coronary Angiography 65 rivastigmine Exelon 65 metastatic gastric 65 Anti Tumor Activity 65 lexidronam injection 65 Cyclooxygenase 2 65 Squamous Cell Carcinoma 65 Receives Marketing Authorization 65 Carbidopa Levodopa 65 clotrimazole 65 allogeneic hematopoietic cell 65 intranasal corticosteroid 65 Investigational Agent 65 Non Alcoholic Fatty 65 Erythropoietic 65 Serostim ® 65 panitumumab Vectibix 65 Boceprevir 65 Replacement Therapy 65 Multaq dronedarone 65 erythematosus 65 Parenteral Nutrition 65 SinuNase TM 65 Atherosclerotic 65 moderate renal impairment 65 ST Segment Elevation 65 HCV Genotype 65 Adult Stem Cell Therapy 65 deferiprone 65 standard chemotherapy regimen 65 Intra arterial 65 Azathioprine 65 metastatic neuroendocrine tumors